# Study to Evaluate an Influenza Vaccine Candidate

> **NCT00540228** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1006 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza Vaccine GSK1247446A - 4 different formulations
- **BIOLOGICAL:** Fluarix™

## Key facts

- **NCT ID:** NCT00540228
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10-05
- **Primary completion:** 2008-05-08
- **Final completion:** 2008-05-08
- **Target enrollment:** 1006 (ACTUAL)
- **Last updated:** 2019-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540228, "Study to Evaluate an Influenza Vaccine Candidate". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00540228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*